Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00824070 · ClinicalTrials.gov registry record · Phase 1
Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects
A Phase 1 study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- Phase 1
- Development phase
- 105
- Enrollment target
NCT00824070 is a Phase 1 study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 105 participants.
The verdict
NCT00824070, a Phase 1 study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 105 participants
- Enrollment target
Study Summary
This study is being conducted to assess the concentration of besifloxacin, moxifloxacin, or gatifloxacin in aqueous humor samples collected following topical instillation of the associated formulation in subjects undergoing cataract surgery.
Interventions
- DRUG Besifloxacin hydrochloride
- DRUG moxifloxacin hydrochloride
- DRUG gatifloxacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00824070
The ClinicalTrials.gov registry entry for NCT00824070 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Besifloxacin hydrochloride is the first listed.
NCT00824070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00824070 about?
NCT00824070 is a clinical study titled "Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects". This study is being conducted to assess the concentration of besifloxacin, moxifloxacin, or gatifloxacin in aqueous humor samples collected following topical instillation of the associated formulation in subjects undergoing cataract surgery.
What is the current status of trial NCT00824070?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 105 participants. The study started on 2009-02. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00824070?
The interventions under investigation include: Besifloxacin hydrochloride (DRUG), moxifloxacin hydrochloride (DRUG), gatifloxacin (DRUG).
Who is sponsoring clinical trial NCT00824070?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.